BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19394641)

  • 1. Detection of elevated proteins in peritoneal dissemination of gastric cancer by analyzing mass spectra data of serum proteins.
    Kojima T; Yoshikawa K; Saga S; Yamada T; Kure S; Matsui T; Uemura T; Fujimitsu Y; Sakakibara M; Kodera Y; Kojima H
    J Surg Res; 2009 Jul; 155(1):13-7. PubMed ID: 19394641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
    Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
    Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protein profiles of serum in gastric cancer at a high-risk area by SELDI-TOF mass spectrometry].
    Wang YS; Shen J; Yu JK; Zhang L; Ma JL; You WC; Pan KF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Sep; 42(9):677-80. PubMed ID: 19175180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
    Zhang GQ; Du J; Pang D
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
    Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
    Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of serum biomarkers for pancreatic adenocarcinoma by proteomic analysis.
    Guo J; Wang W; Liao P; Lou W; Ji Y; Zhang C; Wu J; Zhang S
    Cancer Sci; 2009 Dec; 100(12):2292-301. PubMed ID: 19775290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients.
    Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
    J Zhejiang Univ Sci B; 2006 Mar; 7(3):235-40. PubMed ID: 16502512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein profiling of post-prostatic massage urine specimens by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to discriminate between prostate cancer and benign lesions.
    Okamoto A; Yamamoto H; Imai A; Hatakeyama S; Iwabuchi I; Yoneyama T; Hashimoto Y; Koie T; Kamimura N; Mori K; Yamaya K; Ohyama C
    Oncol Rep; 2009 Jan; 21(1):73-9. PubMed ID: 19082445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of hemoglobin-alpha and -beta subunits as potential serum biomarkers for the diagnosis and prognosis of ovarian cancer.
    Woong-Shick A; Sung-Pil P; Su-Mi B; Joon-Mo L; Sung-Eun N; Gye-Hyun N; Young-Lae C; Ho-Sun C; Heung-Jae J; Chong-Kook K; Young-Wan K; Byoung-Don H; Hyun-Sun J
    Cancer Sci; 2005 Mar; 96(3):197-201. PubMed ID: 15771624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surface enhanced laser desorption/ionization time-of-flight mass spectrometry profiling of serum in detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis].
    Cheng L; Zhou L; Tao L; Zhang M; Cui JF; Liu YK
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2526-30. PubMed ID: 18067823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Screening of differentially expressed proteins associated with directional highly lymphatic metastasis in ovarian carcinoma cell lines using SELDI-TOF-MS technology].
    Guan X; Li DR; Wang Q; Li L; Ruan HY; Zhang W
    Ai Zheng; 2008 Nov; 27(11):1155-60. PubMed ID: 19000445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Establish predictive model of colorectal cancer by using surface enhanced laser desorption/ionization-time of flight-mass spectrometry].
    Lai YH; Xu JM; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
    Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):995-7. PubMed ID: 19035201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A serum protein signature with high diagnostic value in bacterial endocarditis: results from a study based on surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Fenollar F; Goncalves A; Esterni B; Azza S; Habib G; Borg JP; Raoult D
    J Infect Dis; 2006 Nov; 194(10):1356-66. PubMed ID: 17054064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Identification of serum biomarkers for ovarian cancer using protein chips and time of flight mass spectrometry technology].
    Wang Q; Li L; Li DR; Zhang W; Wei X; Zhang JQ; Tang Y
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):544-8. PubMed ID: 17083841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
    Geng X; Wang F; Li YG; Zhu GP; Zhang WM
    J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of gastric cancer by serum proteomic fingerprinting.
    Poon TC; Sung JJ; Chow SM; Ng EK; Yu AC; Chu ES; Hui AM; Leung WK
    Gastroenterology; 2006 May; 130(6):1858-64. PubMed ID: 16697748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of diagnostic biomarkers for pancreatic cancer in immunodepleted serum by SELDI-TOF MS.
    Xue A; Gandy RC; Chung L; Baxter RC; Smith RC
    Pancreatology; 2012; 12(2):124-9. PubMed ID: 22487522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proteinchip-flight mass spectrometry for screening differentially expressed proteins in the serum of cervical cancer patients].
    Cai SN; Liu GB; Guo XH; Chen JG; Zhang J; Wu YL; Liang WJ; Luo RC
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):32-5. PubMed ID: 19218106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulated expression of complement factor I: a potential suppressive protein for gastric cancer identified by serum proteome analysis.
    Liu W; Liu B; Xin L; Zhang Y; Chen X; Zhu Z; Lin Y
    Clin Chim Acta; 2007 Feb; 377(1-2):119-26. PubMed ID: 17067565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.